Lipella Pharmaceuticals Inc (LIPO) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lipella Pharmaceuticals Inc   (LIPO)


Lipella Pharmaceuticals Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Lipella Pharmaceuticals Inc's ROI in the third quarter of 2025?
Lipella Pharmaceuticals Inc recorded a cumulative net loss of $-5 million during 12 months ending in the third quarter of 2025, resulting in a negative return on investment (ROI) of -197.29%.

Within the Healthcare sector 710 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2025 quarter, so far to 3710, from total ROI ranking in the second quarter of 2025 at 3868.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM 20.87 % 8.02 % -17.52 % -39.01 % -36.83 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2 3 4 2 1
Return On Investment (TTM) -197.29 % -209.16 % -220.98 % -261.69 % -190.76 %
LIPO's Overall Ranking # 3710 # 3868 # 3700 # 3551 # 4052
Seq. Investment Change TTM 2.35 % 13.67 % 21.13 % -14.23 % -8.53 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -5 -6 -5 -5 -4

LIPO Company Profile >> Back to LIPO Roi Comparisons >> See Annual LIPO Return On Investment



Return On Investment LIPO's Ranking
Within: No.
Industry # 337
Sector # 711
Overall # 3710

Return On Investment Statistics
High Average Low
-146.96 %
-196.6 %
-261.69 %
(Dec 31 2023)   (Dec 31 2024)







Financial Statements
Lipella Pharmaceuticals Inc's III. Quarter Investments $ 2 Millions LIPO's Balance sheet
Lipella Pharmaceuticals Inc's III. Quarter Income $ -1 Millions Quarterly LIPO's Income Statement
LIPO's Income by Division See LIPO's Income by Division


LIPO Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022

Total Investments in Millions 2 3 5 0 0
Y / Y Investment Growth -39.86 % -33.11 % - - -
Net Income in Millions -5 -5 -3 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -261.34 % -144.71 % -54.44 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
LIPO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for LIPO's Competitors
Subscribers only: Roi for Lipella Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for LIPO's Customers

Other Ratios
LIPO's Roa LIPO's Inventory Turnover Ratio LIPO's Growth Rates LIPO's Dividend Statistics
LIPO's Profitability Ratios LIPO's Asset Turnover Ratio LIPO's Dividend Growth
LIPO's Roe LIPO's Valuation Ratios LIPO's Financial Strength Ratios LIPO's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-26T07:42:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.